Inge Marie Svane

Inge Marie Svane

Clinical Professor


  1. 2013
  2. Published

    In-chip fabrication of free-form 3D constructs for directed cell migration analysis

    Olsen, M. H., Hjortø, Gertrud Malene, Hansen, M., Met, Özcan, Svane, Inge Marie & Larsen, N. B., 21 Dec 2013, In : Lab On a Chip. 13, 24, p. 4800-4809 10 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  3. Published

    Functional characterization of Foxp3-specific spontaneous immune responses

    Larsen, S. K., Munir, S., Woetmann, Anders , Frøsig, T. M., Ødum, Niels, Svane, Inge Marie, Becker, J. C. & Andersen, Mads Hald, Dec 2013, In : Leukemia. 27, 12, p. 2332-40 9 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  4. Published

    HLA-Restricted CTL That Are Specific for the Immune Checkpoint Ligand PD-L1 Occur with High Frequency in Cancer Patients

    Munir, S., Andersen, G. H., Met, Özcan, Donia, M., Frøsig, T. M., Larsen, S. K., Klausen, T. W., Svane, Inge Marie & Andersen, Mads Hald, 15 Mar 2013, In : Cancer Research. 73, 6, p. 1764-76 13 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  5. Published

    Analysis of Survivin-Specific T Cells in Breast Cancer Patients Using Human DCs Engineered with Survivin mRNA

    Met, Özcan & Svane, Inge Marie, 2013, Synthetic Messenger RNA and Cell Metabolism Modulation. Vol. 969. p. 275-292 18 p. (Methods in Molecular Biology).

    Research output: Chapter in Book/Report/Conference proceedingBook chapterResearchpeer-review

  6. Published

    Comparison of clinical grade type 1 polarized and standard matured dendritic cells for cancer immunotherapy

    Hansen, M., Hjortø, Gertrud Malene, Donia, M., Met, Özcan, Larsen, N. B., Andersen, M. H., Thor Straten, P. & Svane, Inge Marie, 2013, In : Vaccine. 31, 4, p. 639-46 8 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  7. Published

    Depletion of T lymphocytes is correlated with response to temozolomide in melanoma patients

    Iversen, T. Z., Brimnes, M. K., Nikolajsen, K., Andersen, R. S., Hadrup, S. R., Andersen, M. H., Bastholt, L. & Svane, Inge Marie, 2013, In : OncoImmunology. 2, 2, p. 1-10 10 p., e23288.

    Research output: Contribution to journalJournal articleResearchpeer-review

  8. Published

    FDG PET scans as evaluation of clinical response to dendritic cell vaccination in patients with malignant melanoma

    Engell-Noerregaard, L., Hendel, H. W., Johannesen, H. H., Alslev, L. & Svane, Inge Marie, 2013, In : Cancer Immunology, Immunotherapy. 62, 1, p. 17-25 8 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  9. Published

    Methods to Improve Adoptive T-Cell Therapy for Melanoma: IFN-γ Enhances Anticancer Responses of Cell Products for Infusion

    Donia, M., Hansen, M., Sendrup, S. L., Iversen, T. Z., Ellebæk, E., Andersen, M. H., Straten, P. T. & Svane, Inge Marie, 2013, In : Journal of Investigative Dermatology. 133, 2, p. 545-52 8 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  10. Published

    Silencing of the glucocorticoid-induced leucine zipper improves the immunogenicity of clinical-grade dendritic cells

    Cathelin, D., Met, Özcan & Svane, Inge Marie, 2013, In : Cytotherapy. 15, 6, p. 740-749 10 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  11. Published

    The immune checkpoint regulator PD-L1 is a specific target for naturally occurring CD4(+) T cells

    Munir, S., Andersen, G. H., Svane, Inge Marie & Andersen, Mads Hald, 2013, In : OncoImmunology. 2, 4, 9 p., e23991.

    Research output: Contribution to journalJournal articleResearchpeer-review

ID: 4054758